RPg Family Wealth Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-370
Closed -$18.8K 273
2019
Q3
$18.8K Hold
370
0.01% 233
2019
Q2
$16.8K Sell
370
-247
-40% -$11.5K 0.01% 237
2019
Q1
$29.4K Buy
617
+340
+123% +$16.9K 0.02% 201
2018
Q4
$14.4K Hold
277
0.01% 189
2018
Q3
$17.2K Buy
+277
New +$16.4K 0.01% 195
2017
Q1
Sell
-195
Closed -$11.4K 277
2016
Q4
$11.4K Sell
195
-245
-56% -$13.4K 0.01% 248
2016
Q3
$23.7K Hold
440
0.02% 160
2016
Q2
$32.4K Sell
440
-127
-22% -$8.97K 0.01% 157
2016
Q1
$36.2K Buy
+567
New +$35.8K 0.03% 141

Other funds holding BMY

RPg Family Wealth Advisory's BMY Position: Q4 2019 in Review

RPg Family Wealth Advisory sold out of Bristol-Myers Squibb (BMY) in Q4 2019, closing a stake of 370 shares — an estimated $18.8K sold.

RPg Family Wealth Advisory first reported a position in BMY in Q1 2016 and held it in 9 quarters. The position peaked at $36.2K in Q1 2016. 2,219 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • RPg Family Wealth Advisory reported no remaining Bristol-Myers Squibb position as of Q4 2019 after selling out during the quarter.
  • RPg Family Wealth Advisory sold 370 Bristol-Myers Squibb shares in Q4 2019, an estimated $18.8K.
  • RPg Family Wealth Advisory first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 9 quarters.
  • RPg Family Wealth Advisory's Bristol-Myers Squibb position peaked at $36.2K in Q1 2016.
  • 2,219 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on RPg Family Wealth Advisory's 13F filing for Q4 2019, filed 12 Feb 2020.